About us
Science
Pipeline
News
Careers
Connect
Legal
About us
Creating a world where people
no longer
suffer from neuropsychiatric illness
Jump to
Leadership
Investors
Leadership
Our Leadership Team
Our leadership team has made pivotal contributions to 13 FDA approvals and $7B in M&A and public company value.
Kevin Ryan
Co-founder and Chairman
Blake Mandell
Co-founder and CEO
Benjamin Kelmendi, MD
Co-founder and Chief Scientific Advisor
Martin Stogniew, PhD
Chief Development Officer
Amanda Jones, PharmD
Sr. VP, Clinical Development
Learn More
Investors
Our Lead Investors
Read More
Alpha Wave
Learn More
Read More
Integrated
Learn More